The American Society of Hematology’s annual meeting is the flagship event for clients developing drugs in hematological malignancies. The volume and quality of content is unparalleled, with major implications for trends in corporate development. The ONCrg team of experts is optimally positioned to interpret the large body of clinical presentations at ASH and distill it into key insights by providing meaningful context for the data.
Drawing on expertise honed year-round by our dedicated disease area specialists, ONCrg prepares detailed agendas identifying high-impact presentations. During and immediately after the conference, our team of experts sifts through the presentations, paying close attention to details while also placing them into the context of the clinical landscape at large. Thereby, ONCrg’s unique conference reports provide clients with clear, digestible top-line trends backed by granular developments. Clients also have access to our analysts post-conference to gather additional commentary and Q&A to guide strategic decision making.
Ask our Conference Lead Analyst about ONCrg Conference coverage.